# Ernexa Therapeutics Inc.: Form SC 13D, filed Feb 5, 2018

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D
- Filed: 2018-02-05
- Accepted by EDGAR: Feb 5, 2018, 08:00 ET
- Period: not reported
- Accession: 0001477932-18-000647
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000147793218000647/ntn_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000147793218000647/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000147793218000647/ntn_sc13d.htm

Filed Feb 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001477932-18-000647. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.